BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turck CW, Guest PC, Maccarrone G, Ising M, Kloiber S, Lucae S, Holsboer F, Martins-de-Souza D. Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response. Front Mol Neurosci 2017;10:272. [PMID: 28912679 DOI: 10.3389/fnmol.2017.00272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Zhang L, He S, Xie Z, Zhang J, Ge C, Sun G, Huang J, Li H. Integrated Module of Multidimensional Omics for Peripheral Biomarkers (iMORE) in patients with major depressive disorder: rationale and design of a prospective multicentre cohort study. BMJ Open 2022;12:e067447. [DOI: 10.1136/bmjopen-2022-067447] [Reference Citation Analysis]
2 Yang Q, Xing Q, Yang Q, Gong Y. Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning. Computational and Structural Biotechnology Journal 2022;20:5054-64. [DOI: 10.1016/j.csbj.2022.09.014] [Reference Citation Analysis]
3 Lin CH, Su H, Hung CC, Lane HY, Shiea J. Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry. Molecules 2021;26:4457. [PMID: 34361610 DOI: 10.3390/molecules26154457] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Heurich M, Föcking M, Mongan D, Cagney G, Cotter DR. Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis. Mol Psychiatry 2021. [PMID: 34226666 DOI: 10.1038/s41380-021-01197-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
5 Shi Y, Song R, Wang L, Qi Y, Zhang H, Zhu J, Zhang X, Tang X, Zhan Q, Zhao Y, Swaab DF, Bao A, Zhang Z. Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study. Journal of Affective Disorders 2020;277:620-30. [DOI: 10.1016/j.jad.2020.08.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kim EY, Ahn HS, Lee MY, Yu J, Yeom J, Jeong H, Min H, Lee HJ, Kim K, Ahn YM. An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks. Biomedicines 2020;8:E455. [PMID: 33126421 DOI: 10.3390/biomedicines8110455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
7 Wåhlén K, Ernberg M, Kosek E, Mannerkorpi K, Gerdle B, Ghafouri B. Significant correlation between plasma proteome profile and pain intensity, sensitivity, and psychological distress in women with fibromyalgia. Sci Rep 2020;10:12508. [PMID: 32719459 DOI: 10.1038/s41598-020-69422-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
8 van Buel EM, Meddens MJM, Arnoldussen EA, van den Heuvel ER, Bohlmeijer WC, den Boer JA, Muller Kobold A, Boonman-de Winter LJM, van Rumpt D, Timmers LFJ, Veerman MFA, Kamphuis JS, Gladkevich AV, Schoevers RA, Luiten PGM, Eisel ULM, Bosker FJ, Klein HC. Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers. J Psychosom Res 2019;125:109796. [PMID: 31470255 DOI: 10.1016/j.jpsychores.2019.109796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Silva-costa LC, Carlson PT, Guest PC, de Almeida V, Martins-de-souza D. Proteomic Markers for Depression. In: Guest PC, editor. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. Cham: Springer International Publishing; 2019. pp. 191-206. [DOI: 10.1007/978-3-030-05542-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]